Neurological adverse events associated with vaccination

Current Opinion in Neurology

Volumn 15, Issue 3, 2002, Pages 333-338

  Piyasirisilp, Sucheep ^a   Hemachudha, Thiravat ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALUMINUM; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; PRESERVATIVE; RABIES VACCINE; THIOMERSAL; VACCINE;

AUTISM; CREUTZFELDT JAKOB DISEASE; DRUG SAFETY; FASCIITIS; FEVER; GIANT CELL ARTERITIS; GUILLAIN BARRE SYNDROME; HUMAN; MENINGOENCEPHALITIS; MULTIPLE SCLEROSIS; MUSCLE HYPOTONIA; NEUROLOGIC DISEASE; NEUROTOXICITY; POLIOMYELITIS; REVIEW; SEIZURE; SKIN INFECTION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; ANIMALS; CATTLE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; DRUG CONTAMINATION; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; INFANT; INFANT, NEWBORN; PRESERVATIVES, PHARMACEUTICAL; VACCINATION; VACCINES;

EID: 0036263760     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200206000-00018     Document Type: Review

References (50)

1. Vaccines and vaccination
2. Measles-mumps-rubella vaccine and autistic spectrum disorder: Report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000
3. Neurological complications of immunization
4. Active immunization in the United States: Developments over the past decade
5. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children
6. Detection and comparative analysis of persistent measles virus infection in Crohn's disease by immunogold electron microscopy
7. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism
8. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association
9. Time trends in autism and in MMR immunization coverage in California
10. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis
11. A shadow falls on hepatitis B vaccination effort
12. Hepatitis B vaccination and the risk of multiple sclerosis
13. Vaccinations and the risk of relapse in multiple sclerosis
14. Adverse events after Japanese encephalitis vaccination: Review of post-marketing surveillance data from Japan and the United States
15. Neurological complications and Japanese encephalitis vaccination
16. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines
17. Giant cell arteritis after influenza vaccination
18. Cavernous sinus syndrome due to vaccination-induced giant cell arteritis
19. Human infection due to recombinant vaccinia-rabies glycoprotein virus
20. Vaccinia (smallpox) vaccine. Recommendations of the Immunization Practices Advisory Committee (ACIP)
21. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine
22. Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998
23. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines
24. Infant immunization with acellular pertussis vaccines in the United States: Assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS)
25. Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: Evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination
26. Hypotonic hyporesponsive episodes in eight pertussis vaccine studies
27. Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: Follow up study
28. Vaccination of children following a previous hypotonic-hyporesponsive episode
29. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
30. Neurologic complications of the reactivation of varicella-zoster virus
31. Varicella vaccination: A critical review of the evidence
32. The effectiveness of the varicella vaccine in clinical practice
33. Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother
34. Chickenpox attributable to a vaccine virus contracted from a vaccinee with zoster
35. Vaccine-associated paralytic poliomyelitis: A retrospective cohort study of acute flaccid paralyses in Brazil
36. Infectious diseases. Polio outbreak raises questions about vaccine
37. Trial of a supplemental dose of four poliovirus vaccines
38. Public health. Aluminum is put on trial as a vaccine booster
39. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle
40. Macrophagic myofasciitis: An emerging entity
41. Central nervous system disease in patients with macrophagic myofasciitis
42. An assessment of thimerosal use in childhood vaccines
43. Universal hepatitis B immunization
44. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants
45. FDA calls bovine-based vaccines currently safe
46. Public health service recommendations for the use of vaccines manufactured with bovine-derived materials
47. Evidence for the transmission of scrapie to sheep and goats from a vaccine against Mycoplasma agalactiae